Edition:
India

Aveo Pharmaceuticals Inc (AVEO.OQ)

AVEO.OQ on NASDAQ Stock Exchange Capital Market

0.71USD
25 Jun 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.71
Open
--
Day's High
--
Day's Low
--
Volume
30,348
Avg. Vol
1,021,027
52-wk High
$3.58
52-wk Low
$0.50

About

AVEO Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's platform delivers insights into cancer and related disease. The Company's product candidates include Tivozanib, Ficlatuzumab, AV-203 and AV-380. Tivozanib is a selective long half-life vascular endothelial growth factor tyrosine kinase inhibitor (VEGF TKI)... (more)

Overall

Beta: 1.22
Market Cap(Mil.): $454.30
Shares Outstanding(Mil.): 118.31
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates